85 related articles for article (PubMed ID: 20090310)
1. Platelet-type von Willebrand disease: results of a worldwide survey from the Canadian PT-VWD project.
Othman M; Hamilton A
Acta Haematol; 2010; 123(2):126-8. PubMed ID: 20090310
[No Abstract] [Full Text] [Related]
2. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
Favaloro EJ
Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
[TBL] [Abstract][Full Text] [Related]
3. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
[TBL] [Abstract][Full Text] [Related]
4. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
Dowling SV; Muntz RH; D'Souza S; Ekert H
Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
[TBL] [Abstract][Full Text] [Related]
5. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis.
Favaloro EJ; Patterson D; Denholm A; Mead S; Gilbert A; Collins A; Estell J; George PM; Smith MP
Br J Haematol; 2007 Nov; 139(4):623-6. PubMed ID: 17916098
[No Abstract] [Full Text] [Related]
6. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
[TBL] [Abstract][Full Text] [Related]
7. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
Franchini M; Montagnana M; Lippi G
Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
9. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of bleeding phenotype in PT-VWD compared to type 2B VWD using an electronic bleeding questionnaire.
Kaur H; Ozelo M; Scovil S; James PD; Othman M
Clin Appl Thromb Hemost; 2014 Nov; 20(8):765-71. PubMed ID: 25063765
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
12. Further studies on aggregation of platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Tatewaki W; Hanano M; Nagayama R; Shibata A
Thromb Haemost; 1986 Jun; 55(3):338-41. PubMed ID: 3018956
[TBL] [Abstract][Full Text] [Related]
13. Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease.
Murata M; Fukuyama M; Satoh K; Fujimura Y; Yoshioka A; Takahashi H; Handa M; Kawai Y; Watanabe K; Ikeda Y
J Clin Invest; 1993 Sep; 92(3):1555-8. PubMed ID: 8376606
[TBL] [Abstract][Full Text] [Related]
14. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of subtype 2B von Willebrand disease in a patient with 2A phenotype of plasma von Willebrand factor.
Gaucher C; de Romeuf C; Rauïs-Morret M; Corazza F; Fondu P; Mazurier C
Thromb Haemost; 1995 Apr; 73(4):610-6. PubMed ID: 7495067
[TBL] [Abstract][Full Text] [Related]
16. [Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases].
Guermazi S; Conard J; Samama MM; Dellagi K
Pathol Biol (Paris); 2006 Apr; 54(3):159-65. PubMed ID: 16176858
[TBL] [Abstract][Full Text] [Related]
17. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
18. [Platelet aggregation caused by ristocetin--its implication and action mechanism].
Izuchi Y
Nihon Rinsho; 1978 Dec; 36(12):3848-56. PubMed ID: 372624
[No Abstract] [Full Text] [Related]
19. Evaluation of the abnormal platelet function in von Willebrand disease by the blood filtration test.
Pareti FI; Cattaneo M; Carpinelli L; Zighetti ML; Bressi C; Mannucci PM; Ruggeri ZM
Thromb Haemost; 1996 Sep; 76(3):460-8. PubMed ID: 8883287
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance.
Enayat MS; Guilliatt AM; Lester W; Wilde JT; Williams MD; Hill FG
Br J Haematol; 2006 Jun; 133(6):664-6. PubMed ID: 16704444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
